The IHC results for paired NAT and tumor tissue are listed in Table 2; they indicate that positive staining of tumor tissue and negative staining of NAT were discovered in 59% of the patients, positive staining of both tumor tissue and NAT in 31%, and negative staining of both tumor tissue and NAT in 10%. Here, BRD2 is linked to neoplasm.